| AM251 |
CB1 receptor antagonist / inverse agonist |
1mg |
Asc-088-1mg |
 ASCENT SCIENTIFIC LTD. |
More Info
|
| AM251 |
CB1 receptor antagonist / inverse agonist |
10mg |
Asc-088-10mg |
 ASCENT SCIENTIFIC LTD. |
More Info
|
| AM251 |
CB1 receptor antagonist / inverse agonist |
50mg |
Asc-088-50mg |
 ASCENT SCIENTIFIC LTD. |
More Info
|
| AM404 |
Anandamide transport inhibitor |
10mg |
Asc-095-10mg |
 ASCENT SCIENTIFIC LTD. |
More Info
|
| AM404 |
Anandamide transport inhibitor |
50mg |
Asc-095-50mg |
 ASCENT SCIENTIFIC LTD. |
More Info
|
| AM 80 |
Minimum Purity: > 99%. Retinoic acid receptor alpha (RARalpha) agonist that induces differentiation (ED50 = 0.79 nM) and apoptosis of HL-60 cells in vitro. Exhibits antiproliferative effects against a variety of human tumor cells lines (mean value... |
10mg |
3507 |
 TOCRIS BIOSCIENCE |
More Info
|
| AM 80 |
Minimum Purity: > 99%. Retinoic acid receptor alpha (RARalpha) agonist that induces differentiation (ED50 = 0.79 nM) and apoptosis of HL-60 cells in vitro. Exhibits antiproliferative effects against a variety of human tumor cells lines (mean value... |
50mg |
3507 |
 TOCRIS BIOSCIENCE |
More Info
|
| AM 580 |
Minimum Purity: > 98%. An analog of retinoic acid that acts as a selective RARalpha agonist (EC50 values are 0.3, 8.6 and 13 nM for RARalpha, RARbeta and RARgamma respectively). Significantly induces IL-4, IL-5 and IL-13 and inhibits IL-12 and IFN... |
10mg |
760 |
 TOCRIS BIOSCIENCE |
More Info
|
| AM 580 |
Minimum Purity: > 98%. An analog of retinoic acid that acts as a selective RARalpha agonist (EC50 values are 0.3, 8.6 and 13 nM for RARalpha, RARbeta and RARgamma respectively). Significantly induces IL-4, IL-5 and IL-13 and inhibits IL-12 and IFN... |
50mg |
760 |
 TOCRIS BIOSCIENCE |
More Info
|
| AM 630 |
Minimum Purity: > 98%. CB2 antagonist/inverse agonist (Ki = 31.2 nM) that displays 165-fold selectivity over CB1 receptors. Behaves as a weak partial/inverse agonist at CB1 receptors. |
10mg |
1120 |
 TOCRIS BIOSCIENCE |
More Info
|
| AM 630 |
Minimum Purity: > 98%. CB2 antagonist/inverse agonist (Ki = 31.2 nM) that displays 165-fold selectivity over CB1 receptors. Behaves as a weak partial/inverse agonist at CB1 receptors. |
50mg |
1120 |
 TOCRIS BIOSCIENCE |
More Info
|
| AM 251 |
Minimum Purity: > 99%. Potent CB1 receptor antagonist (IC50 = 8 nM, Ki = 7.49 nM) that displays 306-fold selectivity over CB2 receptors. Also potent GPR55 agonist (EC50 = 39 nM). Also available as part of the Cannabinoid CB1 Receptor Tocriset&trad... |
10mg |
1117 |
 TOCRIS BIOSCIENCE |
More Info
|
| AM 251 |
Minimum Purity: > 99%. Potent CB1 receptor antagonist (IC50 = 8 nM, Ki = 7.49 nM) that displays 306-fold selectivity over CB2 receptors. Also potent GPR55 agonist (EC50 = 39 nM). Also available as part of the Cannabinoid CB1 Receptor Tocriset&trad... |
50mg |
1117 |
 TOCRIS BIOSCIENCE |
More Info
|
| AM 251 |
Minimum Purity: > 99%. Potent CB1 receptor antagonist (IC50 = 8 nM, Ki = 7.49 nM) that displays 306-fold selectivity over CB2 receptors. Also potent GPR55 agonist (EC50 = 39 nM). Also available as part of the Cannabinoid CB1 Receptor Tocriset&trad... |
1mg |
1117 |
 TOCRIS BIOSCIENCE |
More Info
|
| AM 404 |
Minimum Purity: > 98%. Competitive and selective inhibitor of carrier-mediated anandamide transport (IC50 = 1 µM). Does not activate CB1 receptors or inhibit anandamide hydrolysis but has been shown to activate native and cloned vanilloid re... |
10mg |
1116 |
 TOCRIS BIOSCIENCE |
More Info
|
| AM 404 |
Minimum Purity: > 98%. Competitive and selective inhibitor of carrier-mediated anandamide transport (IC50 = 1 µM). Does not activate CB1 receptors or inhibit anandamide hydrolysis but has been shown to activate native and cloned vanilloid re... |
50mg |
1116 |
 TOCRIS BIOSCIENCE |
More Info
|
| AM 281 |
Minimum Purity: > 99%. Potent, selective CB1 cannabinoid receptor antagonist/inverse agonist (Ki values are 12 and 4200 nM for CB1 and CB2 receptors respectively). Increases locomotor activity following systemic administration in vivo. Analog of S... |
10mg |
1115 |
 TOCRIS BIOSCIENCE |
More Info
|
| AM 281 |
Minimum Purity: > 99%. Potent, selective CB1 cannabinoid receptor antagonist/inverse agonist (Ki values are 12 and 4200 nM for CB1 and CB2 receptors respectively). Increases locomotor activity following systemic administration in vivo. Analog of S... |
50mg |
1115 |
 TOCRIS BIOSCIENCE |
More Info
|
| AM 1172 |
Minimum Purity: > 98%. Metabolically stable anandamide uptake inhibitor (IC50 = 2.1 - 2.5 µM) and fatty acid amide hydrolase (FAAH) inhibitor (Ki = 3.18 µM). Inhibits N-arachidonylethanolamine (AEA) accumulation (IC50 = 24 µM) an... |
10mg |
3381 |
 TOCRIS BIOSCIENCE |
More Info
|
| AM 114 |
Minimum Purity: > 98%. Inhibitor of the chymotrypsin-like activity of the 20S proteasome (IC50 ~ 1 µM). Displays anticancer activity; inhibits cell growth in human colon cancer HCT116 p53+/+ cells (IC50 = 1.49 µM). |
10mg |
2564 |
 TOCRIS BIOSCIENCE |
More Info
|
| AM 114 |
Minimum Purity: > 98%. Inhibitor of the chymotrypsin-like activity of the 20S proteasome (IC50 ~ 1 µM). Displays anticancer activity; inhibits cell growth in human colon cancer HCT116 p53+/+ cells (IC50 = 1.49 µM). |
50mg |
2564 |
 TOCRIS BIOSCIENCE |
More Info
|
| AM 114 |
Proteasome Inhibitor |
10 mg |
2564/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AM 114 |
Proteasome Inhibitor |
50 mg |
2564/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AM 1172 |
Cannabinoid Transporter Inhibitor |
10 mg |
3381/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AM 251 |
Cannabinoid R1/CB1 Antagonist |
1 mg |
1117/1 |
 R&D SYSTEMS, INC. |
More Info
|
| AM 251 |
Cannabinoid R1/CB1 Antagonist |
10 mg |
1117/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AM 251 |
Cannabinoid R1/CB1 Antagonist |
50 mg |
1117/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AM 281 |
Cannabinoid R1/CB1 Antagonist |
10 mg |
1115/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AM 281 |
Cannabinoid R1/CB1 Antagonist |
50 mg |
1115/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AM 404 |
Cannabinoid Transporter Inhibitor |
10 mg |
1116/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AM 404 |
Cannabinoid Transporter Inhibitor |
50 mg |
1116/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AM 580 |
Retinoic Acid Receptor Agonist |
10 mg |
0760/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AM 580 |
Retinoic Acid Receptor Agonist |
50 mg |
0760/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AM 630 |
Cannabinoid R2/CB2 Antagonist |
10 mg |
1120/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AM 630 |
Cannabinoid R2/CB2 Antagonist |
50 mg |
1120/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AM 80 |
Retinoic Acid Receptor Agonist |
10 mg |
3507/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AM 80 |
Retinoic Acid Receptor Agonist |
50 mg |
3507/50 |
 R&D SYSTEMS, INC. |
More Info
|
| Amanitin |
1 mg; from Amanita phalloides. Formula: C39H54N10O14SLD50: approximately 0.1 mg/kg (oral, man)Molecular weight: Mr = 919. Bicyclic octapeptide that inhibits the RNA polymerase of eukaryotic cells. |
n/a |
10161284001 |
ROCHE APPLIED SCIENCE |
More Info
|
| alpha-Amanitin |
Minimum Purity: > 95%. Inhibitor of RNA polymerase II. Inhibits transcription in eukaryotic cells. Binds and blocks the largest subunits of RNA polymerase II, preventing new ribonucleotides from incorporating into the nascent RNA chain. Potent ama... |
1mg |
4025 |
 TOCRIS BIOSCIENCE |
More Info
|
| alpha-Amanitin |
RNA/DNA Polymerase Inhibitor |
1 mg |
4025/1 |
 R&D SYSTEMS, INC. |
More Info
|
| AMG 9810 |
Minimum Purity: > 98%. Potent and selective, competitive vanilloid TRPV1 receptor antagonist (IC50 = 17 nM). Inhibits capsaicin-, proton-, heat- and endogenous ligand-induced activation of human and rat recombinant TRPV1 receptors. Displays antihy... |
10mg |
2316 |
 TOCRIS BIOSCIENCE |
More Info
|
| AMG 9810 |
Minimum Purity: > 98%. Potent and selective, competitive vanilloid TRPV1 receptor antagonist (IC50 = 17 nM). Inhibits capsaicin-, proton-, heat- and endogenous ligand-induced activation of human and rat recombinant TRPV1 receptors. Displays antihy... |
50mg |
2316 |
 TOCRIS BIOSCIENCE |
More Info
|
| AMG-073 |
AMG-073(Cinacalcet hydrochloride) represents a new class of compounds for the treatment of hyperparathyroidism. Purity is greater than 99%. |
10 mg |
orb60063 |
 BIORBYT LTD. |
More Info
|
| AMG-208 |
AMG 208 is a small molecule inhibitor of c-Met with an IC50 of 9.3 nM. Purity is greater than 99%. |
10 mg |
orb60318 |
 BIORBYT LTD. |
More Info
|
| AMG 9810 |
TRPV Antagonist |
10 mg |
2316/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AMG 9810 |
TRPV Antagonist |
50 mg |
2316/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AMI-193 |
Minimum Purity: > 99%. Selective 5-HT antagonist, which binds to 5-HT2 sites as potently as spiperone but has lower affinity for 5-HT2C receptors. Also a high affinity D2 receptor antagonist (Ki = 3 nM). Lacks the disruptive effect of spiperone on... |
10mg |
524 |
 TOCRIS BIOSCIENCE |
More Info
|
| AMI-193 |
Minimum Purity: > 99%. Selective 5-HT antagonist, which binds to 5-HT2 sites as potently as spiperone but has lower affinity for 5-HT2C receptors. Also a high affinity D2 receptor antagonist (Ki = 3 nM). Lacks the disruptive effect of spiperone on... |
50mg |
524 |
 TOCRIS BIOSCIENCE |
More Info
|
| AMI-1 |
Cell-permeable. A potent and specific protein arginine N-methyltransferase (PRMTs) inhibitor (IC50 = 8.8 µM for human PRMT1 and 3.0 µM for yeast Hmt1p ). Does not compete for the AdoMet (S-adenosyl-L-methionine; SAM) binding site. Also... |
5 mg |
1943-5 |
 BIOVISION, INC. |
More Info
|
| AMI-1 |
Cell-permeable. A potent and specific protein arginine N-methyltransferase (PRMTs) inhibitor (IC50 = 8.8 µM for human PRMT1 and 3.0 µM for yeast Hmt1p ). Does not compete for the AdoMet (S-adenosyl-L-methionine; SAM) binding site. Also... |
25 mg |
1943-25 |
 BIOVISION, INC. |
More Info
|